A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene

Clinical trial NCT03605069 · TERMINATED

Trial details

NCT number

NCT03605069

Sponsor

Phoenicis Therapeutics

Status

TERMINATED

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2018-07-02

Primary completion

2018-12-17

Enrollment

2

View on ClinicalTrials.gov